Oligosol® Manganèse Cobalt
Natural health product licensed in Canada
- Licence holder
- Labcatal S.A.
- NPN or DIN-HM
- 00657905
- Status
- Active licence
- Licence date
- 27 May 2008
- Revision date
- Not provided
- Form
- Aérosol
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| cobalt Source : Gluconate de cobalt | 72.6 microgrammes | Not calculated |
Non-medicinal ingredients
Acide benzoïque
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 4 years | 2 mL | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Enfants | minimum: 2 years ; maximum: 4 years | 1 mL | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Enfants | minimum: 6 months ; maximum: 24 months | 1 mL | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Adultes | Not specified | 2 mL | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Traditionnellement utilisé en oligothérapie pour les états de dystonie neurovégétative, tel le colon irritable.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Ne pas administrer en cas d'hypersensibilité, d'intolérance ou d'allergie connue à un ou plusieurs ingrédients.
Source
Official Health Canada record, licence 00657905
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.